Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1955 1
1957 1
1961 2
1962 1
1963 1
1964 2
1965 3
1966 3
1967 1
1968 2
1969 4
1971 1
1972 2
1974 4
1975 6
1976 2
1977 2
1978 11
1979 11
1980 10
1981 3
1982 12
1983 9
1984 14
1985 8
1986 8
1987 14
1988 18
1989 18
1990 25
1991 15
1992 25
1993 19
1994 19
1995 16
1996 20
1997 10
1998 17
1999 7
2000 11
2001 17
2002 14
2003 26
2004 17
2005 24
2006 25
2007 21
2008 35
2009 42
2010 34
2011 34
2012 31
2013 29
2014 27
2015 43
2016 49
2017 28
2018 27
2019 27
2020 41
2021 45
2022 82
2023 95
2024 86
2025 91
2026 58

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,260 results

Results by year

Filters applied: . Clear all
Page 1
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data.
Yanagisawa T, Mori K, Matsukawa A, Kawada T, Katayama S, Bekku K, Laukhtina E, Rajwa P, Quhal F, Pradere B, Fukuokaya W, Iwatani K, Murakami M, Bensalah K, Grünwald V, Schmidinger M, Shariat SF, Kimura T. Yanagisawa T, et al. Cancer Immunol Immunother. 2024 Jan 30;73(2):38. doi: 10.1007/s00262-023-03621-1. Cancer Immunol Immunother. 2024. PMID: 38289361 Free PMC article.
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.
Matsukawa A, Yanagisawa T, Bekku K, Kardoust Parizi M, Laukhtina E, Klemm J, Chiujdea S, Mori K, Kimura S, Fazekas T, Miszczyk M, Miki J, Kimura T, Karakiewicz PI, Rajwa P, Shariat SF. Matsukawa A, et al. Among authors: yanagisawa t. Eur Urol Oncol. 2024 Aug;7(4):697-704. doi: 10.1016/j.euo.2023.12.005. Epub 2024 Jan 4. Eur Urol Oncol. 2024. PMID: 38182488 Free article.
An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer.
Matsukawa A, Litterio G, Cormio A, Miszczyk M, Kardoust Parizi M, Fazekas T, Tsuboi I, Mancon S, Schulz RJ, Laukhtina E, Rajwa P, Mori K, Chlosta P, Marchioni M, Schips L, Miki J, Kimura T, Shariat SF, Yanagisawa T. Matsukawa A, et al. Among authors: yanagisawa t. Cancers (Basel). 2025 Jan 9;17(2):205. doi: 10.3390/cancers17020205. Cancers (Basel). 2025. PMID: 39857987 Free PMC article. Review.
Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis.
Matsukawa A, Yanagisawa T, Parizi MK, Laukhtina E, Klemm J, Fazekas T, Mori K, Kimura S, Briganti A, Ploussard G, Karakiewicz PI, Miki J, Kimura T, Rajwa P, Shariat SF. Matsukawa A, et al. Among authors: yanagisawa t. Prostate Cancer Prostatic Dis. 2025 Jun;28(2):298-308. doi: 10.1038/s41391-024-00886-0. Epub 2024 Sep 5. Prostate Cancer Prostatic Dis. 2025. PMID: 39237679 Free PMC article.
The future potential of the Stentrode.
John SE, Grayden DB, Yanagisawa T. John SE, et al. Among authors: yanagisawa t. Expert Rev Med Devices. 2019 Oct;16(10):841-843. doi: 10.1080/17434440.2019.1674139. Epub 2019 Oct 9. Expert Rev Med Devices. 2019. PMID: 31568731 No abstract available.
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Fujimoto S, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: yanagisawa t. Int J Clin Oncol. 2025 Jan;30(1):123-133. doi: 10.1007/s10147-024-02649-2. Epub 2024 Oct 28. Int J Clin Oncol. 2025. PMID: 39467994
1,260 results